Genomics of Drug Sensitivity in Cancer |
IOX2
|
Synonyms |
IOX-2, IOX 2, AK176060
|
Targets |
EGLN1
|
Target pathway |
Other
|
PubCHEM ID |
54685215
|
Jsmol |
|
Download molecule |
54685215
|
PUBCHEM IUPAC INCHI |
InChI=1S/C19H16N2O5/c22-15(23)10-20-18(25)16-17(24)13-8-4-5-9-14(13)21(19(16)26)11-12-6-2-1-3-7-12/h1-9,24H,10-11H2,(H,20,25)(H,22,23)
|
Smiles |
O=C2(N(C1(=C(C=CC=C1)C(=C2C(=O)NCC(=O)O)O))CC3(=CC=CC=C3))
|
Cluster number |
20
|
calculated LogS |
-2,61
|
Molecular weight |
352,345
|
calculated LogP |
0,5889
|
H-Acceptors |
7
|
H-Donors |
3
|
Ro5 violations |
0
|
Druglikeness |
-0,097879
|
DrugScore |
0,651525795783831
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
1,4186
|
Rat Acute Toxicity |
2,1694
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability2 |
-0,3461
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,114
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB-
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Nucleus
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-2,834
|